(Press-News.org) Researchers from Mount Sinai School of Medicine will present several key studies at the American Academy of Neurology (AAN) annual meeting, including research providing critical insight into the prognosis and clinical treatment course of people with a certain subtype of Multiple Sclerosis (MS). The meeting is taking place April 9-16 in Honolulu.
In a study titled "Evaluation of Progressive Relapsing MS Patients in the PROMISE Trial," Fred Lublin, MD, Saunders Family Professor of Neurology and the Director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis at The Mount Sinai Medical Center and Michelle Fabian, MD, Neurology Fellow at Mount Sinai School of Medicine, conducted a subanalysis of the PROMISE trial. The clinical trial is a multinational, multicenter, double-blind, placebo-controlled trial evaluating the effects of glatiramer acetate treatment over three years in patients with primary progressive multiple sclerosis (PPMS). PPMS is characterized by steady disease progression, rather than attacks or exacerbations followed by remissions, which people with relapsing-remitting MS experience.
"We were able to analyze data from a well-controlled clinical trial to determine the frequency and clinical consequences of the occurrence of relapses in MS patients who initially have a progressive course," said Dr. Lublin. "Our data indicate that baseline characteristics and disease progression in PRMS differ from those in PPMS. As such, clinicians should consider evaluating the PRMS subgroup differently from those with PPMS in assessing prognosis and clinical course."
The research team evaluated differences in baseline characteristics and disease progression between patients with PPMS and patients with another subtype called progressive relapsing multiple sclerosis (PRMS) to help determine whether disease prognosis and treatment course should be evaluated differently in these subgroups. People with PRMS have steady disease progression, but also experience exacerbations, or relapses.
Using the data from the PROMISE trial, researchers found that 42 of the 943 PPMS patients in the PROMISE trial had documented relapses over the 53 months of the study, which indicates they could be categorized as PRMS. At the end of the study, the PRMS patients had a larger change in the Expanded Disability Status Scale, a method of quantifying disability in multiple sclerosis (0.92 vs. 0.59) than the PPMS patients, and increased risk for sustained disability progression. These results indicate that there is a definable subgroup that will inevitably convert to PRMS, and that disease progression is more rapid in this group. The data will be presented Thursday, April 14, 2011, at 2:00 PM HST.
###
The Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai is one of the first and most comprehensive programs in the United States, focusing on treatment for and research into multiple sclerosis. With state-of-the-art programs in diagnostics, experimental therapeutics, and basic research, the Center emphasizes a multidisciplinary approach to disease management. Close collaboration among researchers and clinicians results in the rapid translation of new discoveries into more effective treatments, giving patients the widest possible range of options.
About The Mount Sinai Medical Center
The Mount Sinai Medical Center encompasses both The Mount Sinai Hospital and Mount Sinai School of Medicine. Established in 1968, Mount Sinai School of Medicine is one of few medical schools embedded in a hospital in the United States. It has more than 3,400 faculty in 32 departments and 15 institutes, and ranks among the top 20 medical schools both in National Institute of Health funding and by U.S. News & World Report. The school received the 2009 Spencer Foreman Award for Outstanding Community Service from the Association of American Medical Colleges.
The Mount Sinai Hospital, founded in 1852, is a 1,171-bed tertiary- and quaternary-care teaching facility and one of the nation's oldest, largest and most-respected voluntary hospitals. U.S. News & World Report consistently ranks The Mount Sinai Hospital among the nation's best hospitals based on reputation, patient safety, and other patient-care factors. Nearly 60,000 people were treated at Mount Sinai as inpatients last year, and approximately 530,000 outpatient visits took place.
For more information, visit http://www.mountsinai.org/.
Find Mount Sinai on:
Facebook: http://www.facebook.com/mountsinainyc
Twitter @mountsinainyc
YouTube: http://www.youtube.com/mountsinainy
Mount Sinai researchers present critical MS data at American Academy of Neurology meeting
2011-04-15
ELSE PRESS RELEASES FROM THIS DATE:
New data from XENON100 narrows the possible range for dark matter
2011-04-15
An International team of scientists in the XENON collaboration, including several from the Weizmann Institute, announced on Thursday the results of their search for the elusive component of our universe known as dark matter. This search was conducted with greater sensitivity than ever before. After one hundred days of data collection in the XENON100 experiment, carried out deep underground at the Gran Sasso National Laboratory of the INFN, in Italy, they found no evidence for the existence of Weakly Interacting Massive Particles – or WIMPs – the leading candidates for the ...
Stickfish Improves Security for Prague Stock Exchange, Thanks to VMware View Virtual Desktops
2011-04-15
Desktop virtualization offers significantly better security in comparison to regular PCs. Regular user PCs suffer from a number of security risks, and security plays an important role in the activities of the stock exchange operator. Employees who process stock exchange data need to be equipped with ever more sophisticated means of data protection.
„Legacy PC suffers number of security threats in our processing and dealing environment as national stock exchange data provider. We have chosen Stickfish as a VDI solution supplier for very high level of desktop security ...
Mayo Clinic finds botox eases painful spinal headaches
2011-04-15
ROCHESTER, Minn. - A Mayo Clinic case study finds Botox may offer new hope to patients suffering disabling low cerebrospinal fluid headaches. The successful treatment also offers new insight into Botox and headache treatment generally. The case study was presented March 13th, 2011 at the American Academy of Neurology meeting in Hawaii.
Low CSF pressure headaches are caused by an internal spinal fluid leak. The pain can range from slight to disabling. The headaches are most commonly triggered by a lumbar puncture. The pain is caused as fluid leaks out and the brain ...
Climate change from black carbon depends on altitude
2011-04-15
Palo Alto, CA—Scientists have known for decades that black carbon aerosols add to global warming. These airborne particles made of sooty carbon are believed to be among the largest man-made contributors to global warming because they absorb solar radiation and heat the atmosphere. New research from Carnegie's Long Cao and Ken Caldeira, along with colleagues George Ban-Weiss and Govindasamy Bala, quantifies how black carbon's impact on climate depends on its altitude in the atmosphere. Their work, published online by the journal Climate Dynamics, could have important implications ...
Drug potency -- what happens in space?
2011-04-15
Some of the Pharmaceuticals intended for the treatment of minor illnesses of astronauts in space may require special packaging and reformulation to remain stable for long periods in the space environment. That's according to Dr. Putcha and her colleagues from NASA, Johnson Space Centre. Their findings, published online in The AAPS Journal suggest that some of the pharmaceuticals stored on space flights may have shorter shelf-life than they do on Earth.
Pharmaceuticals used on space flights are packed and dispensed in special flight-certified containers and stored in ...
Can nudging help fight the obesity epidemic?
2011-04-15
With obesity rates soaring, the government has been promoting nudge – a strategy that does not tell people how to live but encourages them to make healthy choices in respect of diet and exercise.
Experts on bmj.com this week go head to head over whether nudge is an effective way to tackle obesity.
Professor Tim Lang and Dr Geof Rayner, both from the Centre for Food Policy at City University in London, say that nudge is not new and that it is "a smokescreen for, at best, inaction and, at worst, publicly endorsed marketing."
They argue that the nudging strategy portrays ...
Artificial pancreas may improve overnight control of diabetes in adults
2011-04-15
Two small randomised trials published on bmj.com today suggest that closed loop insulin delivery (also known as an artificial pancreas) may improve overnight blood glucose control and reduce the risk of nocturnal hypoglycaemia (a sudden drop in blood glucose levels during the night) in adults with type 1 diabetes.
The number of people with type 1 diabetes is increasing at a rate of 3% per year, particularly in white northern European populations. Lifelong insulin therapy is needed to control blood glucose levels, but the risk of hypoglycaemia remains a major challenge, ...
Controversial TOFT theory of cancer versus SMT model: Authors do battle in BioEssays
2011-04-15
Writing in BioEssays, cancer scientists Ana Soto and Carlos Sonnenschein pit their controversial Tissue Organization Field Theory (TOFT) of the origin of cancer against the widely accepted Somatic Mutation Theory (SMT) in what is believed to be the first time the two theories have formally opposed each other – championed by authors from opposite sides of the debate – in a common forum for discussion.
Soto and Sonnenschein, from Tufts University, argue that SMT, which is based on the accumulation of genetic mutations in cells, not only fails to provide an explanation for ...
Scientists finely control methane combustion to get different products
2011-04-15
Scientists have discovered a method to control the gas-phase selective catalytic combustion of methane, so finely that if done at room temperature the reaction produces ethylene, while at lower temperatures it yields formaldehyde. The process involves using gold dimer cations as catalysts — that is, positively charged diatomic gold clusters. Being able to catalyze these reactions, at or below room temperature, may lead to significant cost savings in the synthesis of plastics, synthetic fuels and other materials. The research was conducted by scientists at the Georgia ...
PhotoInCanvas Develop Canvas Art Shop with Bespoke Designs for Lovers of Photo Canvas
2011-04-15
As their development continues, purveyors of top quality photo canvas prints PhotoInCanvas have introduced a unique Canvas Art Shop. This area of the firm's already vibrant website has a range of categories to suit lovers of all types of art.
PhotoInCanvas has established a name for itself by taking normal jpeg photographs and transforming them into stunning pieces of photo canvas art but the Canvas Art Shop looks to give clients even more choice and inspiration. As well as the Canvas of the Month, all sorts of designs such as animals, children's art, food and drink ...